Trial intelligence / Profile preview

Vitamin D supplementation regimens after hip fracture surgery in elderly patients

2017-001778-40Phase 4Active

Sponsor
Leonor Cuadra Llopart
Start
Oct 2017
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of calcifediol in hip fracture and Vitamin D deficiency (VDD) (2 arms), sponsored by Leonor Cuadra Llopart. Primary endpoints: Functional gain at 6 months with calcifediol loading versus usual practice and Maintenance of functional benefit at 12 months. Started Oct 2017; status: active.

02

Drugs

calcifediol
03

Conditions

hip fractureVitamin D deficiency (VDD)

Beyond the preview

Go deeper on 2017-001778-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-001778-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call